# A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever

> **NCT07126171** · NA · NOT_YET_RECRUITING · sponsor: **Jiangsu Kanion Pharmaceutical Co., Ltd** · enrollment: 400 (estimated)

## Conditions studied

- Chikungunya Fever

## Interventions

- **DRUG:** Reduning injection
- **DRUG:** The simulant of Reduning Injection

## Key facts

- **NCT ID:** NCT07126171
- **Lead sponsor:** Jiangsu Kanion Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2025-11-26
- **Final completion:** 2026-02-18
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07126171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07126171, "A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07126171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*